28.10.2016 • NewsanalyticalbiologicsCatalent

Catalent Starts Madison Expansion Project

Catalent Pharma Solutions has broken ground on a $34 million extension to its biologics manufacturing facility in Madison, Wisconsin, USA. When completed, the additional 22,000 square foot of space will house a 2 x 2,000 liter single-use bioreactor system, which will allow Catalent to support late-phase clinical and commercial production of batches up to 4,000 liters. The investment will also expand its analytical and process development laboratories, as well as providing extra office space.

“Our continued investment in biologics capabilities is in direct response to market demand where underlying growth for large molecules is expected to exceed that for small molecule drugs,” said Barry Littlejohns, Catalent’s president of Drug Delivery Solutions.

The Wisconsin Economic Development Corporation (WEDC) has awarded tax credits of up to $1 million over the next three years to the Somerset, New-Jersey headquartered firm, contingent upon the actual level of investment in Madison during that period.

Opened in April 2013, the Madison facility is home to Catalent’s proprietary GPEx cell line technology and provides development, manufacturing and analytical services for new biological entities (NBEs) and biosimilars. Work to extend the site’s analytical capabilities was completed in January 2016. The company has also completed investments to expand process development capability at the site, integrating a microbioreactor system into its cell line and upstream development process.

Catalent announced late last month that it was planning to acquire Pharmatek Laboratories, a contract drug development and clinical manufacturing firm based in San Diego, California.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.